Journals / Kocaeli Tıp Dergisi / 2022 / Cilt: 11 - Sayı: 1

CardiacFindings afterCOVID-19Treatment and CompletedQuarantine Process

COVID-19 Tedavisi ve Karantina Süreci Tamamlandıktan Sonraki Kardiyak Bulgular

Pages
194–202
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The patients should be evaluated in the Cardiology outpatient clinic to investigate whether they have late-term cardiac effects due to COVID-19 infections.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Our aim was to determine late-term which cardiac effects were in hemogram, biochemical parameters, cardiac biomarkers,Electrocardiography(ECG)andTransthoracicechocardiography(TTE)andwhichcardiaccomplaintswereinthe patientsadmitted to theCardiologyoutpatient clinic aftertheCoronavirusdisease2019 (COVID-19)treatment andquarantine process was completed.
📊
Key Findings & Data:Method:132consecutivepatientsincludedinthisretrospectivestudy.ECGandTTEwereperformed,hemogram,biochemical parameters, cardiac biomarkers; high sensitive cardiac troponin T(hs-cTn), N terminal Pro Btype natriuretic peptid (NT-pro BNP) and D-dimer were studied in all patients on admission.
💡
Conclusion & Impact:Conclusion: The patients should be evaluated in the Cardiology outpatient clinic to investigate whether they have late-term cardiac effects due to COVID-19 infections.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Our aim was to determine late-term which cardiac effects were in hemogram, biochemical parameters, cardiac biomarkers,Electrocardiography(ECG)andTransthoracicechocardiography(TTE)andwhichcardiaccomplaintswereinthe patientsadmitted to theCardiologyoutpatient clinic aftertheCoronavirusdisease2019 (COVID-19)treatment andquarantine process was completed. Method:132consecutivepatientsincludedinthisretrospectivestudy.ECGandTTEwereperformed,hemogram,biochemical parameters, cardiac biomarkers; high sensitive cardiac troponin T(hs-cTn), N terminal Pro Btype natriuretic peptid (NT-pro BNP) and D-dimer were studied in all patients on admission. Results:In thisstudy, we found the following findingsin the patients: the most common co-morbidite was hypertension in 39 (29.5%) patients, the most common complaints of the patients presenting to the Cardiology outpatient clinic was chest pain in 48 (36.40%) patients, the most common EGG finding wassinustachycardia in 11 (8.3%) patients, the most common TTE findingwasmild tricuspid regurgitation in 63 (47.70%)patients.In thisstudywehave found systolicpulmonaryarterysystolic hypertension rate 6.10% and the rate was higher than compared to the normal population. It was remarkable that pericardial hyperechocenicity was detected in 18 (13.60%) patients. We detected elevated D-dimer levels were detected in 24 (18.20%) patients, elaveted NT-pro BNP levels in 15 (11.40%) patients and elevated hs-cTn levels in 9 (6.8 %) patients. Conclusion: The patients should be evaluated in the Cardiology outpatient clinic to investigate whether they have late-term cardiac effects due to COVID-19 infections.

Özet

Giriş: Amacımız, Coronavirus disease 2019 (Covid-19) tedavisi ve karantina süreci tamamlandıktan sonra Kardiyoloji Polikliniğine başvuran hastaların geç dönemde hangi kardiyak şikayetler ile başvurduğunu ve biyokimyasal parametrelerde, kardiyak biyobelirteçlerde, elektrokardiyografi (EKG) ve transtorasik ekokardiyografide (TTE) hangi kardiyak bulguların olduğunu tespit etmekti. Yöntem: Bu retrospektif çalışmaya ardışık 132 hasta dahil edildi. EKG çekildi, TTE yapıldı. Tüm hastalarda başvuruda hemogram, biyokimyasal parametreler, kardiyak biyobelirteçler; yüksek duyarlıklı kardiyak troponin T,N terminal proBtipi natriüretik peptid ve D-dimer çalışıldı. Bulgular: : Kardiyoloji Polikliniğine başvuran hastalarda en sık görülen ko-morbidite hipertansiyon 39 (%29,50), en sık görülen kardiyak şikayet göğüs ağrısı 48 (%36,40), en sık EKGbulgusu sinüstaşikardisi 11 (%8,3), en sık TTE bulgusu hafif triküspit yetersizliğiydi 63 (%47,70). Bu çalışmada sistolik pulmoner arter hipertansiyon oranın %6,10 bulduk ve bu oran normal popülasyona göre daha yüksekti. Perikardiyal hiperekojenitenin 18 (%13,60) hastada saptanması dikkat çekiciydi. YüksekD-dimerseviyesi24(%18,20)hastada,yüksekNT-proBNPseviyesi15(%11,40)hastadaveyüksekhs-cTnseviyesi9 (%6,80) hastada tespit edildi. Sonuç: Hastalar, Covid-19’un geç dönem kardiyak etkilerinin olup olmadığını araştırmak için Kardiyoloji Polikliniğinde değerlendirilmelidir.

🔖

Cite This Article

AYDIN, G., GÖLCÜK, E. (2022). CardiacFindings afterCOVID-19Treatment and CompletedQuarantine Process. Kocaeli Tıp Dergisi, Cilt: 11 - Sayı: 1, 194–202. https://ajindex.com/articles/574655

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Reports[Internet]
  2. Ruan Q, YangK, WangW,Jiang L, Song J.Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846- 848. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;: PMID: 32125452; PMCID: PMC7080116.
  3. Su YB, Kuo MJ, Lin TY,Chien CS, Yang YP,Chou SJ, Leu HB. Cardiovascular manifestation and treatment in COVID-19. J Chin Med Assoc. 2020 Aug;83(8):704-709. PMID: 32433342; PMCID: PMC7493780.
  4. Moreira EM, Gall H, Leening MJ, et al. Prevalence of Pulmonary Hypertension in the General Population: The Rotterdam Study. PLoS One. 2015;10(6):e0130072. Published 2015 Jun 23.
  5. Vakamudi S, Ho N, Cremer PC. Pericardial Effusions: Causes, Diagnosis, and Management. Prog Cardiovasc Dis. 2017 Jan-Feb;59(4):380-388. Epub 2017 Jan 4. PMID: 28062268.
  6. WallsAC,ParkYJ,Tortorici MA, WallA, McGuire AT,VeeslerD.Structure,Function,andAntigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020Apr 16;181(2):281-292.e6.Epub 2020 Mar 9. Erratumin:Cell. 2020Dec 10;183(6):1735.PMID: 32155444; PMCID: PMC7102599.
  7. Landi A, Iannucci V, Nuffel AV, Meuwissen P, Verhasselt B. One protein to rule them all: modulation of cellsurface receptors and molecules byHIVNef.CurrHIVRes.2011Oct;9(7):496-504. PMID: 22103833; PMCID: PMC3290772.
  8. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395: 15; 395(10223): 497–506.
  9. Farina A, Uccello G, Spreafico M, Bassanelli G, Savonitto S.SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade. Eur J Intern Med. 2020;76:100-101.
  10. Asif T, Kassab K, Iskander F, Alyousef T. Acute Pericarditis and Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge. Eur J Case Rep Intern Med. 2020;7(6):001701. Published 2020 May 6.
  11. Zhang L, Long Y, Xiao H, Yang J, ToulonP, Zhang Z. Use of D-dimer in oral anticoagulation therapy. Int J Lab Hematol. 2018 O